MOLBIO logo

Molbio Diagnostics Limited

MOLBIO·NSE
0.00 +0.00 (+0.00%)
Market Cap
PE Ratio
Volume
Day High - Low
52W High-Low
This price may be out of date. Not a live price.
DocStoX Score
4.7/10
Weak
Fair Value
Sign in to see
ROE
15.80%
Strong
P/E
Debt / Equity
Industry
Overall View
Mixed

Price performance

DocStoX take

Supported by quality (7.5), but held back by growth (1.4). Quality looks strong at 7.5, but that is offset by growth at 1.4. We are calling it Mixed rather than resolving the conflict for you. Scored on 3 of 5 measures.

DocStoX score

Low confidence
4.7
/10
Weak
Quality
Excellent
ROE 15.8%
Valuation
No data
No valuation multiples
Growth
Flat
Revenue +7.8% 3Y CAGR
Risk
Elevated
Earnings variability 76%
Momentum
No data
No technical indicators

Scored on 3 of 5 measures — the rest have no data for this company.

At a glance

Market Cap
52W High / Low
Dividend Yield
Promoter Holding
EPS (TTM)
₹62.00
Book Value

Key highlights

  • Profitable in all of the last 5 years
  • Capital works hard — ROCE 21%
  • Profit shrinking 9% a year
  • Growth is weak (1.4/10)
2 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.